398 related articles for article (PubMed ID: 38510646)
1. Exploiting the Achilles' heel of cancer: disrupting glutamine metabolism for effective cancer treatment.
Fan Y; Xue H; Li Z; Huo M; Gao H; Guan X
Front Pharmacol; 2024; 15():1345522. PubMed ID: 38510646
[TBL] [Abstract][Full Text] [Related]
2. Glutamine metabolism in breast cancer and possible therapeutic targets.
Li S; Zeng H; Fan J; Wang F; Xu C; Li Y; Tu J; Nephew KP; Long X
Biochem Pharmacol; 2023 Apr; 210():115464. PubMed ID: 36849062
[TBL] [Abstract][Full Text] [Related]
3. The 'Achilles Heel' of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy.
Hoerner CR; Chen VJ; Fan AC
Kidney Cancer; 2019 Feb; 3(1):15-29. PubMed ID: 30854496
[TBL] [Abstract][Full Text] [Related]
4. Advancing Cancer Treatment by Targeting Glutamine Metabolism-A Roadmap.
Halama A; Suhre K
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158820
[TBL] [Abstract][Full Text] [Related]
5. A Critical Role of Glutamine and Asparagine γ-Nitrogen in Nucleotide Biosynthesis in Cancer Cells Hijacked by an Oncogenic Virus.
Zhu Y; Li T; Ramos da Silva S; Lee JJ; Lu C; Eoh H; Jung JU; Gao SJ
mBio; 2017 Aug; 8(4):. PubMed ID: 28811348
[TBL] [Abstract][Full Text] [Related]
6. Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies.
Wang Z; Liu F; Fan N; Zhou C; Li D; Macvicar T; Dong Q; Bruns CJ; Zhao Y
Front Oncol; 2020; 10():589508. PubMed ID: 33194749
[TBL] [Abstract][Full Text] [Related]
7. Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer.
Ni R; Li Z; Li L; Peng D; Ming Y; Li L; Liu Y
Front Oncol; 2023; 13():1143798. PubMed ID: 36959802
[TBL] [Abstract][Full Text] [Related]
8. The metabolic importance of the glutaminase II pathway in normal and cancerous cells.
Dorai T; Pinto JT; Denton TT; Krasnikov BF; Cooper AJL
Anal Biochem; 2022 May; 644():114083. PubMed ID: 33352190
[TBL] [Abstract][Full Text] [Related]
9. Glutamine Is Required for M1-like Polarization of Macrophages in Response to Mycobacterium tuberculosis Infection.
Jiang Q; Qiu Y; Kurland IJ; Drlica K; Subbian S; Tyagi S; Shi L
mBio; 2022 Aug; 13(4):e0127422. PubMed ID: 35762591
[TBL] [Abstract][Full Text] [Related]
10. Glutaminase inhibition as potential cancer therapeutics: current status and future applications.
Cyriac R; Lee K
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2290911. PubMed ID: 38078371
[TBL] [Abstract][Full Text] [Related]
11. Targeting glutamine metabolism as a therapeutic strategy for cancer.
Jin J; Byun JK; Choi YK; Park KG
Exp Mol Med; 2023 Apr; 55(4):706-715. PubMed ID: 37009798
[TBL] [Abstract][Full Text] [Related]
12. Finding an "Achilles' heel" of cancer: the role of glucose and glutamine metabolism in the survival of transformed cells.
Yuneva M
Cell Cycle; 2008 Jul; 7(14):2083-9. PubMed ID: 18635953
[TBL] [Abstract][Full Text] [Related]
13. Glutamine addiction in tumor cell: oncogene regulation and clinical treatment.
Li X; Peng X; Li Y; Wei S; He G; Liu J; Li X; Yang S; Li D; Lin W; Fang J; Yang L; Li H
Cell Commun Signal; 2024 Jan; 22(1):12. PubMed ID: 38172980
[TBL] [Abstract][Full Text] [Related]
14. Metabolic reprogramming of glutamine involved in tumorigenesis, multidrug resistance and tumor immunity.
Xiao-Yan W; Xiao-Xia Y; Peng-Fei S; Zong-Xue Z; Xiu-Li G
Eur J Pharmacol; 2023 Feb; 940():175323. PubMed ID: 36535492
[TBL] [Abstract][Full Text] [Related]
15. The Pleiotropic Effects of Glutamine Metabolism in Cancer.
Bott AJ; Maimouni S; Zong WX
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31167399
[TBL] [Abstract][Full Text] [Related]
16. Sex differences in brain tumor glutamine metabolism reveal sex-specific vulnerabilities to treatment.
Sponagel J; Jones JK; Frankfater C; Zhang S; Tung O; Cho K; Tinkum KL; Gass H; Nunez E; Spitz DR; Chinnaiyan P; Schaefer J; Patti GJ; Graham MS; Mauguen A; Grkovski M; Dunphy MP; Krebs S; Luo J; Rubin JB; Ippolito JE
Med; 2022 Nov; 3(11):792-811.e12. PubMed ID: 36108629
[TBL] [Abstract][Full Text] [Related]
17. Glutamine addiction and therapeutic strategies in pancreatic cancer.
Ren LL; Mao T; Meng P; Zhang L; Wei HY; Tian ZB
World J Gastrointest Oncol; 2023 Nov; 15(11):1852-1863. PubMed ID: 38077649
[TBL] [Abstract][Full Text] [Related]
18. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
Dai W; Xu L; Yu X; Zhang G; Guo H; Liu H; Song G; Weng S; Dong L; Zhu J; Liu T; Guo C; Shen X
J Hepatol; 2020 May; 72(5):909-923. PubMed ID: 31899205
[TBL] [Abstract][Full Text] [Related]
19. Glutamine Addiction and Therapeutic Strategies in Lung Cancer.
Vanhove K; Derveaux E; Graulus GJ; Mesotten L; Thomeer M; Noben JP; Guedens W; Adriaensens P
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634602
[TBL] [Abstract][Full Text] [Related]
20. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.
Du D; Liu C; Qin M; Zhang X; Xi T; Yuan S; Hao H; Xiong J
Acta Pharm Sin B; 2022 Feb; 12(2):558-580. PubMed ID: 35256934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
